Drug Shortage Report for 20% PROSOL
| Report ID | 24792 |
| Drug Identification Number | 02141450 |
| Brand name | 20% PROSOL |
| Common or Proper name | 20% PROSOL |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | PHENYLALANINE HISTIDINE TRYPTOPHAN LEUCINE ARGININE THREONINE ALANINE DL-METHIONINE GLYCINE GLUTAMIC ACID PROLINE L-ASPARTIC ACID TYROSINE LYSINE SERINE VALINE ISOLEUCINE |
| Strength(s) | 1G 1.18G 0.32G 1.08G 1.96G 0.98G 2.76G 0.76G 2.06G 1.02G 1.34G 0.6G 0.05G 1.35G 1.02G 1.44G 1.08G |
| Dosage form(s) | LIQUID |
| Route of administration | INTRAVENOUS |
| Packaging size | 2000 mL |
| ATC code | B05BA |
| ATC description | I.V. SOLUTIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2017-11-15 |
| Actual start date | 2017-11-15 |
| Estimated end date | 2017-12-15 |
| Actual end date | 2017-11-21 |
| Shortage status | Resolved |
| Updated date | 2017-11-22 |
| Company comments | Customers can use the following alternate code upon their clinical judgement: JB6584- Travasol 10% 1000 ml |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2017-11-22 | English | Compare |
| v7 | 2017-11-21 | French | Compare |
| v6 | 2017-11-21 | English | Compare |
| v5 | 2017-11-16 | French | Compare |
| v4 | 2017-10-10 | English | Compare |
| v3 | 2017-10-10 | English | Compare |
| v2 | 2017-10-10 | French | Compare |
| v1 | 2017-10-10 | English | Compare |
Showing 1 to 8 of 8